Offstream
news

---

Changes

1. Mexican health regulator COFEPRIS approves the emergency use of the anti-COVID-19 oral drug Paxlovid manfuactured by Pfizer.
   2022-01-15 01:10:38 (First version)
2. Mexican health regulator COFEPRIS approves the emergency use of Pfizer's anti-COVID-19 oral drug Paxlovid.
   (Current version)

---

Related

The Therapeutic Goods Administration grants provisional approval for Pfizer's Paxlovid COVID-19 drug and Merck & Co.'s Molnupiravir COVID-19 drug.
2022-01-20

South Korea signs an agreement to buy an additional 400,000 doses of Pfizer's Paxlovid COVID-19 drug.
2022-01-5

The Medicines and Healthcare products Regulatory Agency approves the use of Pfizer's anti-viral oral drug Paxlovid for high-risk patients.
2021-12-31

South Korea authorizes the emergency use of the anti-viral oral drug Paxlovid manufactured by Pfizer for high-risk patients over the age of 12 years, becoming the first drug to be approved for use in the country.
2021-12-27

The Israeli government finalizes an agreement with Pfizer to purchase 100,000 courses of the anti-viral drug Paxlovid for high-risk patients over the age of 12 years, with delivery expected to begin in one week.
2021-12-25

The Food and Drug Administration grants emergency use authorization for Pfizer's antiviral COVID-19 oral pill named Paxlovid for at-risk people over the age of 12 years, becoming the first at-home oral treatment to be approved by the FDA.
2021-12-22

The final results of a trial of Paxlovid conducted by Pfizer shows 89% cut of risk of hospitalization and death in high-risk patients and is likely to work against the Omicron variant.
2021-12-14

Mexican health regulator COFEPRIS approves the emergency use of Eli Lilly and Co's injectable combination of bamlanivimab and etesevimab to treat mild to moderate COVID-19 cases in people over the age of 12 years who weigh at least 40 kg.
2021-12-1

The Mexican Federal Commission for the Protection against Sanitary Risk issues an emergency use authorization for the Moderna COVID-19 vaccine.
2021-08-18

Mexico begins vaccinations with the Pfizer-BioNTech vaccine. An intensive care unit nurse in Mexico City becomes the first person in the country to receive the vaccine.
2020-12-24